NEXT GENERATION SEQUENCING ITEMS

The U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH) in Bellavista, Callao, Peru, is procuring specialized reagents to support next-generation sequencing (NGS) projects involving human samples, using Illumina’s MiSeq and MiniSeq platforms. The contract requires delivery of six specific reagent kits: PhiX Control v3, MiSeq Reagent Kit v3 (600-cycle), Nextera XT DNA Library Preparation Kit (96 samples), Nextera XT Index Kit v2 Set A, MiniSeq High Output Reagent Kit (300-cycles), and Nextera XT Index Kit v2 Set B, with precise quantities including two PhiX controls, ten MiSeq kits, three DNA library preparation kits, one each of Index Sets A and B, and six MiniSeq kits. All materials are time-sensitive and must be maintained under strict cold chain conditions from manufacture through delivery. The vendor is required to disclose expiration dates as soon as they are available and secure explicit approval from NAMRU SOUTH before shipping any items to ensure usability upon arrival. None of the items are classified as hazardous materials. The procurement is issued as an 8(a) Sole Source set-aside under NAICS code 424210, reflecting it is limited to qualified small disadvantaged businesses. The solicitation, numbered VEID260013_1301365570, was posted on May 29, 2026, with a response deadline of June 13, 2026. Performance is tied directly to the delivery schedule upon award, and technical specifications mandate that sequencing kits yield over 2.0 gigabases per run with high Q30 quality scores and include internal controls for run validation. The contracting office is the Naval Medical Research Center in Silver Spring, Maryland, and primary point of contact is Luciana Encinas, with secondary support from Shamai Carter.